Cobalt Protoporphyrin Pretreatment Protects Human Embryonic Stem Cell-Derived Cardiomyocytes From Hypoxia/Reoxygenation Injury In Vitro and Increases Graft Size and Vascularization In Vivo

Jun Luo(Central South University), Margaret D. Allen(Virginia Mason Medical Center)
Stem Cells Translational Medicine
April 15, 2014
Cited by 25


Related Papers